“The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.”, Invest Ophthalmol Vis Sci, vol. 49, no. 10, pp. 4340-6, 2008.
, “SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.”, Ophthalmology, vol. 116, no. 3, pp. 504-12, 2009.
, “SCORE Study report 3: study design and baseline characteristics.”, Ophthalmology, vol. 116, no. 9, pp. 1770-1777.e1, 2009.
, “Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.”, Retina, vol. 30, no. 3, pp. 459-67, 2010.
, “Identification of a potential susceptibility locus for macular telangiectasia type 2.”, PLoS One, vol. 7, no. 8, p. e24268, 2012.
, “SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.”, Am J Ophthalmol, vol. 170, pp. 25-31, 2016.
, “SCORE2 Report 2: Study Design and Baseline Characteristics.”, Ophthalmology, vol. 124, no. 2, pp. 245-256, 2017.
, “SCORE2 Report 2: Study Design and Baseline Characteristics.”, Ophthalmology, vol. 124, no. 2, pp. 245-256, 2017.
,